| Drug Name | Cerdelga (eliglustat) |
|---|---|
| Drug Class | |
| Risk minimization type |
Patient Card
Healthcare provider guide
|
| Specialty (Theraputic area) | |
| Risk |
- Drug-drug interaction: Use with CYP2D6 and/or CYP3A inhibitors, strong CYP3A inducers, P-gp or CYP2D6 substrates - Use of eliglustat in patients who are CYP2D6 indeterminate metabolizers or non-genotyped patients - Off label use in Gaucher disease type 2 and 3 |
| Patient card |
|
| Health care provider guide |
|